• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

鲍恩病中p53、p16和沉默调节蛋白1的肿瘤特异性重叠表达：一例报告

Overlapping tumor-specific expression of p53, p16, and sirtuin 1 in Bowen's disease: A case report.

作者信息

Takada Tomoaki

机构信息

Sumikawa Takada Dermatology Clinic Sapporo-shi Japan.

出版信息

Clin Case Rep. 2020 Oct 27;8(12):3394-3399. doi: 10.1002/ccr3.3400. eCollection 2020 Dec.

DOI:10.1002/ccr3.3400
PMID:33363940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7752376/
Abstract

Understanding the impact of inactivating mutations in on the and tumor suppressor genes may yield new insight into the oncogenic mechanisms underlying Bowen's disease.

摘要

了解[基因名称]中失活突变对[基因名称]和[基因名称]肿瘤抑制基因的影响，可能会为鲍温病潜在的致癌机制带来新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/1a7937647934/CCR3-8-3394-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/936cb6e77ce0/CCR3-8-3394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/f9ee316630ce/CCR3-8-3394-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/1a7937647934/CCR3-8-3394-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/936cb6e77ce0/CCR3-8-3394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/f9ee316630ce/CCR3-8-3394-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a1/7752376/1a7937647934/CCR3-8-3394-g003.jpg

相似文献

1
Overlapping tumor-specific expression of p53, p16, and sirtuin 1 in Bowen's disease: A case report.鲍恩病中p53、p16和沉默调节蛋白1的肿瘤特异性重叠表达：一例报告
Clin Case Rep. 2020 Oct 27;8(12):3394-3399. doi: 10.1002/ccr3.3400. eCollection 2020 Dec.
2
Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.鲍温病中p53、p21（Waf1/Cip1）和转化生长因子β（3）免疫组化染色分析
Dermatology. 2001;202(1):9-15. doi: 10.1159/000051577.
3
The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.p63、p16 和 p53 免疫组化在鉴别脂溢性角化病、光化性角化病和 Bowen 病中的诊断价值。
Dermatol Ther. 2021 Mar;34(2):e14817. doi: 10.1111/dth.14817. Epub 2021 Feb 8.
4
Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.免疫组织化学染色 p16 在 Bowen 病的诊断中是一种有用的辅助检测手段。
Pathology. 2013 Jun;45(4):402-7. doi: 10.1097/PAT.0b013e328360c064.
5
Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease.转化生长因子-β3免疫组化染色在乳腺外佩吉特病中过表达，但在鲍温病中表达下调。
Int J Dermatol. 2001 Apr;40(4):262-7. doi: 10.1046/j.1365-4362.2001.01026.x.
6
P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.鲍温病和鲍温样丘疹病中P16（INK4A）的表达
J Med Assoc Thai. 2006 Sep;89(9):1460-5.
7
Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis.p2lWaf1/Cip1免疫组化染色在鲍恩病中过表达，但在播散性浅表性汗孔角化症中未过表达。
Br J Dermatol. 1999 Oct;141(4):647-51. doi: 10.1046/j.1365-2133.1999.03102.x.
8
Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease.鲍温病中的人乳头瘤病毒感染：p53表达缺失而非p16(INK4a)过表达与人乳头瘤病毒相关的鲍温病相关。
J Dermatol. 2014 Oct;41(10):878-84. doi: 10.1111/1346-8138.12613. Epub 2014 Sep 9.
9
Correlation of p16 and pRb expression with HPV detection in Bowen's disease.鲍温病中p16和pRb表达与HPV检测的相关性
J Cutan Pathol. 2006 Sep;33(9):629-33. doi: 10.1111/j.1600-0560.2006.00499.x.
10
Perianal Bowen's disease: a clinicopathologic study of 47 patients.肛周鲍恩病：47例患者的临床病理研究
Dis Colon Rectum. 1997 Nov;40(11):1286-93. doi: 10.1007/BF02050810.

引用本文的文献

1
The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer.沙特乳腺癌患者中核及细胞质沉默信息调节因子1蛋白表达的免疫组化预后价值
Biomolecules. 2025 Jan 2;15(1):50. doi: 10.3390/biom15010050.

本文引用的文献

1
Primary Intra-Osseous Basaloid Squamous Cell Carcinoma of Mandible: Report of Rare Case with Proposed Diagnostic Criteria.下颌骨原发性骨内基底样鳞状细胞癌：罕见病例报告及拟诊标准
J Coll Physicians Surg Pak. 2019 Dec;29(12):1215-1217. doi: 10.29271/jcpsp.2019.12.1215.
2
Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma.细胞质 SIRT1 通过阻碍卵巢癌中的上皮-间充质转化抑制细胞迁移和侵袭。
Mol Cell Biochem. 2019 Sep;459(1-2):157-169. doi: 10.1007/s11010-019-03559-y. Epub 2019 Jul 17.
3
The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
SIRT1 在癌症的 DNA 损伤反应和表观遗传改变中的作用。
Int J Mol Sci. 2019 Jun 28;20(13):3153. doi: 10.3390/ijms20133153.
4
Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.通过免疫组织化学方法评估N-钙黏蛋白在口腔鳞状细胞癌中的预后潜力
J Coll Physicians Surg Pak. 2017 Aug;27(8):475-478.
5
Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?黑色素瘤和非黑色素瘤皮肤癌的化学预防：烟酰胺能发挥作用吗？
Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):5-12. doi: 10.1111/phpp.12328. Epub 2017 Aug 8.
6
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.一项烟酰胺用于皮肤癌化学预防的 3 期随机试验。
N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197.
7
Molecular tumorigenesis of the skin.皮肤的分子肿瘤发生
J Med Invest. 2014;61(1-2):7-14. doi: 10.2152/jmi.61.7.
8
Bowen's disease: A six-year retrospective study of treatment with emphasis on resection margins.鲍恩病：一项为期六年的治疗回顾性研究，重点关注切除边缘。
Acta Derm Venereol. 2014 Jul;94(4):431-5. doi: 10.2340/00015555-1771.
9
Janus-faced role of SIRT1 in tumorigenesis.SIRT1 在肿瘤发生中的双面角色。
Ann N Y Acad Sci. 2012 Oct;1271(1):10-9. doi: 10.1111/j.1749-6632.2012.06762.x.
10
Cells of origin and tumor-initiating cells for nonmelanoma skin cancers.非黑色素瘤皮肤癌的起源细胞和肿瘤起始细胞。
Cancer Lett. 2013 Sep 10;338(1):82-8. doi: 10.1016/j.canlet.2012.05.008. Epub 2012 May 11.